Blog
ALF is proud to once again be a member of the Bank of America Chicago Marathon Official Charity Program for the 2025 race, which takes place on Sunday, October 12, 2025, starting in iconic Grant Park.
American Liver Foundation’s (ALF) National Legacy Gala will be held Wednesday, Oct. 29 at Gotham Hall in New York City honoring those who have made significant contributions to the liver community.
ALF is excited to announce the launch of the ALF Living Donor Network, the first-ever non-directed donor (formerly called altruistic donor) database created to connect individuals who wish to donate part of their liver with transplant centers nationwide to help patients in need.
American Liver Foundation (ALF) is proud to announce that Gerald I. Shulman, MD, PhD, is the recipient of its 2025 Distinguished Scientific Achievement Award (DSAA).
On behalf of the entire American Liver Foundation (ALF) family, we express our heartfelt condolences to the family of our beloved former board member, Michael Kerr, who passed away from complications associated with liver disease.
American Liver Foundation (ALF) applauds U.S. Senators Bill Cassidy, M.D. (R-LA) and Chris Van Hollen (D-MD) for introducing life-saving legislation to help cure Americans suffering from hepatitis C (HCV).
ALF, American Liver Foundation, 2025 Poster Competitions Announced, Cameron Adams, what patients want to know.
ALF’s Liver Life Advocacy Summit was held in Washington, D.C. April 29th and 30th and brought together patients, caregivers and families from coast to coast to champion legislative priorities for liver health and help the 100 million Americans affected by some form of liver disease.
American Liver Foundation (ALF) will bring together patients, caregivers, and family members affected by liver disease from across the country for the Liver Life Advocacy Summit in Washington, D.C., on Tuesday, April 29 and 30 to champion ALF’s 2025 legislative priorities.
ALF anuncia el primer registro de pacientes en español para todo tipo de enfermedades hepáticas para ayudar a garantizar que las necesidades y experiencias de la comunidad hispana/latina se incorporen a los datos que pueden ayudar a conducir a futuros tratamientos y curas para la enfermedad hepática.
ALF announces the first-ever Spanish-language patient registry for all types of liver diseases to help ensure that the needs and experiences of the Hispanic/Latino community will be incorporated into the data that may help lead to future treatments and cures for liver disease.
Unleash your inner foodie and experience a distinct evening of dining all for a good cause. Funds raised benefit the 100 million Americans affected by liver disease through resources, education and support services and help advance our advocacy efforts on Capitol Hill and liver disease research.